77,541 Shares in Encompass Health Co. (NYSE:EHC) Bought by Lightrock Netherlands B.V.

Lightrock Netherlands B.V. purchased a new stake in Encompass Health Co. (NYSE:EHC) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 77,541 shares of the company’s stock, valued at approximately $7,196,000. Encompass Health makes up approximately 2.5% of Lightrock Netherlands B.V.’s investment portfolio, making the stock its 20th largest holding. Lightrock Netherlands B.V. owned about 0.08% of Encompass Health as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in EHC. Cetera Investment Advisers lifted its stake in Encompass Health by 5.7% in the second quarter. Cetera Investment Advisers now owns 12,353 shares of the company’s stock worth $1,060,000 after acquiring an additional 664 shares during the last quarter. CWM LLC raised its holdings in shares of Encompass Health by 27.8% in the 3rd quarter. CWM LLC now owns 8,164 shares of the company’s stock valued at $789,000 after purchasing an additional 1,776 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after purchasing an additional 252 shares during the last quarter. CHICAGO TRUST Co NA purchased a new position in Encompass Health in the third quarter valued at $221,000. Finally, Oliver Luxxe Assets LLC lifted its holdings in Encompass Health by 43.7% during the 3rd quarter. Oliver Luxxe Assets LLC now owns 60,553 shares of the company’s stock worth $5,852,000 after buying an additional 18,407 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on EHC. StockNews.com downgraded Encompass Health from a “buy” rating to a “hold” rating in a report on Friday. Royal Bank of Canada raised their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. William Blair restated an “outperform” rating on shares of Encompass Health in a report on Friday. KeyCorp lifted their price target on shares of Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday. Finally, Truist Financial restated a “buy” rating and issued a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, Encompass Health presently has a consensus rating of “Buy” and a consensus price target of $107.67.

Encompass Health Price Performance

Shares of EHC opened at $98.66 on Tuesday. The company has a market capitalization of $9.94 billion, a price-to-earnings ratio of 22.12, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90. Encompass Health Co. has a fifty-two week low of $72.38 and a fifty-two week high of $104.55. The firm has a 50-day simple moving average of $96.20 and a 200-day simple moving average of $95.35. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%. On average, equities research analysts anticipate that Encompass Health Co. will post 4.76 earnings per share for the current year.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.